急诊物质使用就诊后精神分裂症谱系障碍的转化风险
这项基于加拿大安大略省人群的回顾性队列研究(2008年1月至2022年3月)纳入9 844 497名14至65岁无精神病性障碍史个体,比较因物质使用伴或不伴精神病性症状急诊就诊后转化为精神分裂症谱系障碍的风险。物质所致精神病性障碍组转化风险显著升高(aHR 163.2,3年风险18.5%),无精神病性症状的物质使用组相对风险较低(aHR 9.8)但绝对转化例数更多(9969 vs 3029)。
要点
- 物质所致精神病性障碍后3年转化为精神分裂症谱系障碍的风险为18.5%,远高于一般人群的0.1%。
- 无精神病性症状的物质使用急诊就诊者相对风险较低但绝对转化例数更多(9969 vs 3029)。
- 大麻使用在伴精神病性症状就诊中转化风险最高(aHR 241.6),在无精神病性症状就诊中排第三(aHR 14.3)。
核心结论
- 因物质使用至急诊就诊与后续发生精神分裂症谱系障碍的风险升高相关。
- 物质所致精神病性障碍的相对转化风险更高,但无精神病性症状的物质使用更普遍且绝对转化例数更多。
研究设计与样本
- 基于人群的回顾性队列研究,纳入加拿大安大略省2008年1月至2022年3月所有14至65岁无精神病性障碍史个体,共9 844 497人。
- 将因物质使用伴或不伴精神病性症状的急诊就诊者与一般人群比较,使用原因别风险模型估计关联。
主要发现
- 物质所致精神病性障碍组年龄性别调整风险比(aHR)为163.2(95%CI 156.1-170.5),3年转化风险18.5%,一般人群为0.1%。
- 无精神病性症状的物质使用组aHR为9.8(95%CI 9.5-10.2),3年转化风险1.4%,绝对转化例数9969例,物质所致精神病性障碍组为3029例。
- 伴精神病性症状就诊中大麻使用转化风险最高(aHR 241.6,95%CI 225.5-258.9),无精神病性症状就诊中大麻使用排第三(aHR 14.3,95%CI 13.5-15.2)。
- 较年轻年龄和男性与更高的转化风险相关,男性风险在年轻个体中更大,尤其在大麻使用情况下。
临床怎么用
- 急诊接诊物质使用患者时应评估精神分裂症谱系障碍的转化风险,尤其针对物质所致精神病性障碍、大麻使用、年轻男性等高危特征。
- 对无精神病性症状的物质使用就诊者也需关注后续精神健康,因其绝对转化例数更多,可考虑早期干预和咨询。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Episodes of substance-induced psychosis are associated with increased risk of developing a schizophrenia spectrum disorder. However, there are limited data on the transition risk for substance use without psychosis. OBJECTIVES: To quantify the risk of transition to schizophrenia spectrum disorder following an incident emergency department (ED) visit for (1) substance-induced psychosis and (2) substance use without psychosis and to explore factors associated with transition. DESIGN, SETTINGS, AND PARTICIPANTS: A population-based retrospective cohort study (January 2008 to March 2022) of all individuals, aged 14 to 65 years, in Ontario, Canada, with no history of a psychotic disorder. Individuals with incident ED visits for substance use with and without psychosis were compared with members of the general population. MAIN OUTCOMES AND MEASURES: Transition to schizophrenia spectrum disorder using a chart-validated algorithm. Associations between ED visits for substance use and subsequent transition were estimated using cause-specific hazard models. RESULTS: The study included 9 844 497 individuals, aged 14 to 65 years (mean [SD] age, 40.2 [14.7] years; 50.2% female) without a history of psychosis. There were 407 737 individuals with an incident ED visit for substance use, of which 13 784 (3.4%) ED visits were for substance-induced psychosis. Individuals with substance-induced psychosis were at a 163-fold (age- and sex-adjusted hazard ratio [aHR], 163.2; 95% CI, 156.1-170.5) increased risk of transitioning, relative to the general population (3-year risk, 18.5% vs 0.1%). Individuals with an ED visit for substance use without psychosis had a lower relative risk of transitioning (aHR, 9.8; 95% CI, 9.5-10.2; 3-year risk, 1.4%), but incurred more than 3 times the absolute number of transitions (9969 vs 3029). Cannabis use had the highest transition risk among visits with psychosis (aHR, 241.6; 95% CI, 225.5-258.9) and the third-highest risk among visits without psychosis (aHR, 14.3; 95% CI, 13.5-15.2). Younger age and male sex were associated with a higher risk of transition, and the risk of male sex was greater in younger compared with older individuals, particularly for cannabis use. CONCLUSIONS AND RELEVANCE: The findings of this cohort study suggest that ED visits for substance use were associated with an increased risk of developing a schizophrenia spectrum disorder. Although substance-induced psychoses had a greater relative transition risk, substance use without psychosis was far more prevalent and resulted in a greater absolute number of transitions. Several factors were associated with higher transition risk, with implications for counseling and early intervention.
引用
- Myran DT, Harrison LD, Pugliese M, et al. Transition to Schizophrenia Spectrum Disorder Following Emergency Department Visits Due to Substance Use With and Without Psychosis. JAMA Psychiatry. 2023. PMID: 37755727. doi:10.1001/jamapsychiatry.2023.3582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。